Mj. Reinhardt et al., FDG-PET EVALUATION OF RETROPERITONEAL METASTASES OF TESTICULAR CANCERBEFORE AND AFTER CHEMOTHERAPY, The Journal of nuclear medicine, 38(1), 1997, pp. 99-101
We describe a patient whose primary tumor was a testicular teratocarci
noma predominantly composed of embryonal carcinoma. Before chemotherap
y, the retroperitoneal metastases demonstrated heterogeneous, increase
d glucose metabolism as measured by 2-[F-18]fluoro-2-deoxy-D-glucose a
nd PET(FDG-PET). After chemotherapy, FDG uptake was reduced to normal
Values despite increased tumor volume. Histology revealed a pure matur
e teratoma. This observation suggests that further studies are needed
to determine whether tumor differentiation of testicular teratocarcino
ma metastases can be assessed by measuring glucose metabolism.